# Amazon in Podcasts, Apr 20–26: AWS Strength, Healthcare Upside > Weekly podcast summary for Amazon, Apr 20–26, 2026. Body to be imported from the source email. # Amazon & Cloud Computing Weekly Newsletter **Week of April 22-24, 2026** --- ## 🎙️ Featured Podcast Coverage ### **The Acquirers Podcast** — *April 23, 2026* **Guest: Charles Lemonides, ValueWorks LLC** ValueWorks founder Charles Lemonides made a compelling case for Amazon as an undervalued holding, arguing the stock trades at a significant discount to its sum-of-the-parts valuation. With a current ~$2 trillion market cap, Lemonides estimated Amazon's businesses could be worth $3 trillion or potentially higher, implying roughly 50% upside. The fund manager noted that the stock has been "dead money for a long time... no one's made money in this thing for, I don't know, five years or something" — but attributed this to valuation compression rather than execution issues. He characterized the period as the company growing into an inflated 2021 valuation. **On AWS:** Lemonides stated "AWS may only be growing at 22% a year or whatever it is. But man, is it growing. And man, do they have unlimited demand." **On Leadership:** Addressing concerns about Jeff Bezos reportedly raising a $100B private equity fund, Lemonides expressed confidence in Amazon's depth: "He has done an incredible job of building a very complex organization with a lot of people in it that are doing really well. And it's not a cult of personality and it's not all about him... for the past, I don't know, five, seven years, it's been a big team of people executing." --- ### **Motley Fool Money** — *April 22, 2026* **Hosts: Rachel Warren, Lou Whiteman, Travis William** The team discussed Amazon's major healthcare push: distributing GLP-1 medications (weight-loss drugs) through Amazon Pharmacy and OneMedical with same-day delivery, expanding to up to 4,500 cities by year-end 2026. **Strategic Logic:** Rachel Warren framed the move as "Amazon is looking to solve here is to fix one of the messier parts of healthcare, which is getting the actual medication to consumers. And Amazon's really leading into their strengths as a logistics and pharmacy powerhouse." Lou Whiteman drew parallels to Amazon's core business: "GLP-1s are splashy, so I see why this is a big deal. But this is what Amazon has been doing for a while... There are a lot of people running out to the pharmacy, especially for maintenance drugs, like a statin or a GLP-1, where you don't need it this second... It can be a hassle to get." **Competitive Impact:** The panel agreed this move is "more disruptive to your traditional pharmacy chains like CVS, per se, than necessarily the telehealth companies", with Amazon "deliberately avoiding" direct competition with telehealth providers like Hims and Ro because "quite frankly, they don't have to". **Pricing Transparency:** Travis William highlighted a key advantage: "You go to Amazon, and you can actually see what you're going to pay. And when you walk into a CVS or a Walgreens, especially buying something like an EpiPen... you have no idea if you're going to be paying nothing or you're going to be paying $600." --- ## 📰 Related News This Week ### **Organizational Changes** Amazon is eliminating traditional product job titles within its Ring and Blink units as part of a broader organizational redesign, replacing them with a simplified "Builder" job family to emphasize customer value creation. The change affects product teams rather than performance status or compensation.[1](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NkrIVb-2FgA4pmf2rMXQwGcOjnamAo84r9E9QIVecavvjz3CH6lfWVamMHg2CU4OwvfSwpEmR0bSI5oIHh8CxtRLkww38VaaJiXP6DtYo9JXIrOtUU_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWJ4oAmr7CeNrqKtnPslLhayU1cJ5Roo8zMzTRtTI8fvwNnnc32tPvu0BUkYQuWKmeBmZbqlwowjHY216eX0z6YStGM0iqgFiRy-2FCX3LUDExT3DL0-2FnoMsRhaQUbQP3EP0g-3D-3D) ### **Cloud Competition — Microsoft Licensing Lawsuit** Microsoft will face a mass lawsuit alleging it overcharged thousands of British businesses to use its Windows Server software on services provided by Amazon, Google, and Alibaba.[1](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NkrIVb-2FgA4pmf2rMXQwGcOjnamAo84r9E9QIVecavvjz3CH6lfWVamMHg2CU4OwvfSwpEmR0bSI5oIHh8CxtRLnRKKuNyFnRd8akQXv5kpJLsnIz_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWOMAXT-2F2U-2FOTDeXvLoOY7e-2FDUSEIWyVoIB0BsgQOGD9dy30Mc7IpNqJ2wXjxJrx9sTw1wcwMaYy9BXxN0IkZefEeZ11sixkp7kcD9jPkc3gxXoMX99-2BCGYDhgmZhlGZRMw-3D-3D) Competition lawyer Maria Luisa Stasi is bringing the case on behalf of 60,000 businesses with claims worth up to $2.8B.[1](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NkrIVb-2FgA4pmf2rMXQwGcOjnamAo84r9E9QIVecavvjz3CH6lfWVamMHg2CU4OwvfSwpEmR0bSI5oIHh8CxtRLnRUCo8I-2Bi3-2FWC20TaytIwW2daA_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWCxJHdKzlo9LrdDOuOV-2FpuY12XWXBJvuVQ16lu1N4mFX2Ot8Mpw7O0QV80liBQwAdXQeJzAYeTkOoFWrhLflxHK3-2Bm3kQXkXzC5DEdlZH6eUUo9i1728ekT6EhLSShoScg-3D-3D) This highlights ongoing regulatory scrutiny in the cloud infrastructure market. ### **Data Center Infrastructure Boom** Amazon-backed X-Energy, which uses nuclear reactors to power AI, raised roughly $1B this week while Blackstone plans to raise about $2B for its new data-center acquisition vehicle.[1](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NkrIVb-2FgA4pmf2rMXQwGcOjnamAo84r9E9QIVecavvjz3CH6lfWVamMHg2CU4OwvfSwpEmR0bSI5oIHh8CxtRLlhgVj-2FgUA9VezbTGmkKYGbcZgC_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWPVzsOfX2INf5gZxfD71i9g-2Bw-2FtNJrZsZTxLH8q00bOJWrxc1fxqto-2BHzMpp9iC1za-2Bk0jPgrbVJj8khfa5omHSjI2cA-2BW4F5d51A7a4FpCwEZlWadpWr5RjoG9CXyDwGA-3D-3D) This underscores the massive capital flowing into AI infrastructure — a tailwind for AWS demand. --- ## 💡 Investment Takeaways **Bullish Signals:** - Sum-of-parts valuation suggests meaningful upside (~50% per Lemonides) - AWS demand characterized as "unlimited" despite growth moderation - Healthcare/pharmacy initiative leverages core logistics strengths - Leadership depth viewed as sufficient post-Bezos transition - AI infrastructure buildout continues to drive cloud demand **Risks to Monitor:** - Stock has been "dead money" for ~5 years despite strong execution - Healthcare execution risk in a complex, regulated industry - Competitive intensity in cloud (Microsoft licensing disputes) - No bearish counterpoints represented in this week's podcast coverage --- **Sources:** - [The Acquirers Podcast — April 23, 2026](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NkrIVb-2FgA4pmf2rMXQwGcOj7Xrvnw1UJ3E8ziJsVr7bAr629OlgMnpj3jeR30x7PvUZeFYC-2FGmPCO-2FwEbogVdPQ-2BoQheUPcJS0zZ1J3lipfpC8SMBDFe0Du6glY2y7cBhA-3D-3DZwYx_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWLOKaerZHRcmoiJQkaYu9KNSdGoDye8Iuj-2BQbV4r3TDuILfNzAGzOaXwpY9N2GAvFnxLI7BI-2BNtcs4nuN-2BryRRpAm35HeiGRXCH4fEsSVCyjcBw3ZCfJJ5rG6SmI2Qsq-2Bw-3D-3D) - [Motley Fool Money — April 22, 2026](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NkrIVb-2FgA4pmf2rMXQwGcOirhzPegG85cXoUgPxDb7aSxN5WWw9N8L8YBrq8fd4yXoV0u7jHwRQ3HZhVJ5rsH88ed2mTowXH-2BwGEo7hOI1b7YgaEnhW14On-2FUuU7sFOjWg-3D-3Dby2f_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWALdWzu2D3wIpeB8Js-2BCOxxOJ2111izFBTuj313P-2FuXE8-2F3NfZOoDX1caa0Bcu0zjpGVn6F1mw6UihwNzTLgIXQbkV9OChMEH80CBDu4hZrKL-2FufOHPdSPERy8Zln7bXgA-3D-3D) ## Additional web sources used: web[1](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7Npt-2BiYVNEk7qqO5e9VwRMYkqTu4lka-2FyTZayX6Zs2Raiaylk_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWG0AnlEioX7Z0mVxQ5e4vzEmi0-2Fz5p3nVQHD9x8hC-2FyWxZNojJ9oYvP-2BbPpQC4d9SBUgz35BNjgA9TJoW2EY9i5oe5U7-2F5TOf3DQOrRl01Ban1MvmF0o-2BT6NmIQqAQ3glw-3D-3D), web[2](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NgBdiZcdkC-2FVHID-2BCVe8PhqIKmCAmrEVzgYSh9u3NFGb-2Bpobs2GOvdqObL6jvJ-2F-2B5RpoaAVYLAjtHVzsjR0SSpA-3DqtN9_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWONyt0zNWTXQqbaS39y02TkSFz6Sn-2Bm14DaEYpO75YOwRex-2FFHB-2FJEWQ4CCS9fGw8oYXPa2-2FKbgq4mqef37eM08Zvvb6zc8Yd-2FzskewcIuYY9ebyXIuxF3QKr1jXRmnMeA-3D-3D), web[3](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NuRY1RFN6ljOGuk91QAGItbhEHVEsd9TNs1xWoEGMgEJ-2F6qZiupwvxy924VkBZ60bwRHrxDqGIhx1HfmYKhHKVo-3DtvDY_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWLQeompqFj9pK1jLE-2FjQK1Rq6EViGagkxglgt3-2FioT6okkGXVwlYUPPfjKbD9QijfVmn40jFRdwqx6828hWipY1hSAd9J1VM9JKvt7LJUeXyIPCPcynUYjHgUaiCWmVf2Q-3D-3D), web[4](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7Nt6zFOcZgAgMYqu5ZFCtXpkRJMY1cjzBL4OLijz6Bd-2BC073Kh6WouMS-2Bp7Evf-2Bt8mBi6J5YwY22cVdo-2BGyUcXMmfPLWFKaOjRA5kFKJo1MBf1Pj6ruLgqmnxrAPk0WdkEw-3D-3D6kaI_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWGKTHORLj8qdFQOmxmmbKSU-2FUHGWANmTuNSuurvv6vlaSmgN-2FrkL-2BuBubdRxR3jRMAuBwH1DLSatiQ4A43RsA3pIN5gPjGW9szCnf-2B3nWG8b-2BXjEX-2FGvJiKhVvxEKN9Clg-3D-3D), web[5](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NsYQYyJYcXmA8U3BUiGtUac-2B0h3-2BB4CTb2migLkTD-2F6DTows_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWJYDw7zEgJNy2S8SiAinZoauqVMdCcg34drBaxBg5RbW1e-2FA1bauNbohxzEl-2BuJm-2BpIPpHTqDy2ajuiCCNHxM6wlcVDyki0FPoVC1za-2FjjQbmAEJ40f2r88nBi69G69xKw-3D-3D), web[6](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7NgdDxUnN2DkqDVZ3IlVf109818KIfuatTULt4IoheyePws53aZubwfQSJm7pMXrJecpeqsQupC2b6VGSftajTJe5yhOJk84mbScjR-2BPqCXeIUMS7Inmd5KrLMpNXZy-2FdsU9HMMLYOvRJTP5RiuCnv-2BY-3DDIVa_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWIhVqyOyI0-2BPdvP5-2BtpToBOOoPgR820hAtbLCMXHKvFP4FTVqV7MmNMGVenRwKPXpVYfcy2lpXjqJ4-2Fng1wFAdZ0b-2BduFJjFhAG4BhC04t4wGO17jyNUiQffXC1Q5kAeGQ-3D-3D), web[7](http://url7324.matterfact.com/ls/click?upn=u001.idHmPrr2Geh7KYLAsTy7Ngxo3FzVnsoUDiAktWjR8HecLgjBeLVRiHie1saiQ31t81a5zlsBzY-2BiSWZEo166OfgP2w9-2FW8EBpcAVG-2BV0JHZKXRxheGtbEoZ3JlgTlJwvOnhZHYNpvnia3LX0H5X55lRiTeUnl49CTapBBRqGRZ8-3DyJ6q_7mLGwmUci-2BLaXswv9WX1yTgqn3Wad-2FotHhzHgSNAZbVlY04UogEQfkQwSXkiotNkY5P-2FowZVqRBzOlKzAqWjWLjKTvQCg41tNwP0W5C-2B51zrQHjx2XSgycO-2FLCZMk0UEh662YweJH4NtgEAljZw00IohTd7bhU8pJT5T82Vmm0MB9exvvm4APrR1VOCaZZMnlhzvz5DG6yRfNNFHy9MU2w-3D-3D)